Compound information
- Natural Products
- ZC972890
- Molecular Formula
- C18H24N2O5
- Molecular Weight
- 348.168521868 g/mol
- Structure
-
- IUPAC Name
- ethyl 4-[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]piperazine-1-carboxylate
- InChI
- InChI=1S/C18H24N2O5/c1-4-25-18(22)20-11-9-19(10-12-20)17(21)8-6-14-5-7-15(23-2)16(13-14)24-3/h5-8,13H,4,9-12H2,1-3H3/b8-6+
- InChI Key
- VKUABJPHGPQOEZ-SOFGYWHQSA-N
- SMILES
- CCOC(=O)N1CCN(C(=O)/C=C/c2ccc(OC)c(OC)c2)CC1
- Source
- ZINC000002621768
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 25 | Ring Count | 2 |
Heteroatom Count | 7 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 68.31 Å2 | LogP | 1.977 |
LogS | -2.416 | LogD | 3.34 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.057 | Pgp substrate | 0.151 |
HIA | 0.973 | F20 % | 0.982 |
F30 % | 0.592 | Caco-2 | -4.554 |
MDCK | -4.743 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.873 | PPB | 88.372 |
VD | 1.056 | Fu | 0.719 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.022 | CYP1A2 substrate | 0.666 |
CYP2A6 substrate | 0.473 | CYP2B6 substrate | 0.583 |
CYP2C19 inhibitor | 0.152 | CYP2C19 substrate | 0.573 |
CYP2C8 substrate | 0.58 | CYP2C9 inhibitor | 0.072 |
CYP2C9 substrate | 0.972 | CYP2D6 inhibitor | 0.018 |
CYP2D6 substrate | 0.621 | CYP2E1 substrate | 0.515 |
CYP3A4 inhibitor | 0.277 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.911 | CL | 4.985 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.167 | Hepatotoxicity | 0.896 |
Mutagenicity | 0.021 | Rat Oral Acute Toxicity | 0.449 |
FDAMDD | 0.292 | Skin Sensitization | 0.003 |
Carcinogenicity | 0.35 | Eye Corrosion | 0.002 |
Eye Irritation | 0.081 | Respiratory Toxicity | 0.062 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.431 | IGC50 | 3.142 |
LC50FM | 3.156 | LC50DM | -0.074 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.359 | NR-AR-LBD | 0.366 |
NR-AhR | 0.083 | NR-Aromatase | 0.032 |
NR-ER | 0.592 | NR-ER-LBD | 0.36 |
NR-PPAR-gamma | 0.174 | SR-ARE | 0.588 |
SR-ATAD5 | 0.837 | SR-HSE | 0.099 |
SR-MMP | 0.01 | SR-p53 | 0.321 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.